TAAR1 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA534236-Each-of-1 | In Stock | ₹ 48,905.50 |
PIPA534236 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 48,905.50
GST (18%): ₹ 8,802.99
Total Price: ₹ 57,708.49
Antigen
TAAR1
Classification
Polyclonal
Conjugate
Unconjugated
Gene
Taar1
Gene Alias
MGC126874; MGC138399; RP11-295F4.9; RTAR1; Snorf33; Ta1; Taar1; TAR1; taR-1; trace amine associated receptor 1; trace amine receptor 1; trace amine-associated receptor 1; trace-amine-associated receptor 1; TRAR1
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
134864
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
Immunohistochemistry (Paraffin)
Concentration
1 mg/mL
Formulation
PBS with 0.1% sodium azide
Gene Accession No.
Q96RJ0
Gene Symbols
Taar1
Immunogen
Synthetic 16 amino acid peptide from N-terminus of human TAAR1.
Quantity
50 μg
Primary or Secondary
Primary
Target Species
Human, Non-human Primate
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Percent identity with other species by BLAST analysis: Human, Chimpanzee, Gibbon, Monkey, Marmoset, Tamarin (100%) Orangutan, Cat, Horse (88%) Bovine, Elephant, Panda, Rabbit, Pig (81%)
- TA1 has been reported in human brain, dorsal root ganglion, olfactory bulb, kidney, liver, lung, pancreas, prostate, skeletal muscle, small intestine, spleen, spinal cord, and stomach
- An EST for TA1 has been identified from a human stomach cancer library
- G-protein Coupled Receptors (GPCRs) comprise one of the largest families of signaling molecules with more than a thousand members currently predicted to exist
- All GPCRs share a structural motif consisting of seven membrane-spanning helices, and exist in both active and inactive forms
- An array of activating ligands participate in the conformation of GPCRs which leads to signaling via G-proteins and downstream effectors
- Ongoing studies have also shown the vast series of reactions which participate in the negative regulation of GPCRs
- This turn-off activity has tremendous implications for the physiological action of the cell, and continues to drive pharmacological research for new drug candidates.